Company intelligence / Profile preview

Escold

Telsiai, Lithuania

Ownership: Private
Development stage: Other

Overview

Escolit is a pharmaceutical manufacturing company founded in 2021 and based in Telsiai, Lithuania. The company operates as a Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO), specializing in the production of generic medicines and high-value dietary supplements. Its diversified product portfolio focuses on chronic therapeutic segments, including cardiology, neurology, psychiatry, and gastroenterology. Escolit is particularly noted for its niche portfolio of liposomal dietary supplements marketed under the Rexsavit brand. The company aims to provide affordable, high-quality medicines with medically proven efficacy to a global patient base.

Therapeutic areas: PsychiatryEndocrinologyGastroenterologyCardiovascularNeurology
Modalities: Small moleculeLiposomal delivery
Industry: Pharma

Beyond the preview

Go deeper on Escold.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escold.

Explore the full profile